BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 1, 2021
View Archived Issues
Bacteriophage delivery of TNF-alpha gene therapy suppresses chondrosarcoma tumors in vivo
Read More
Merck & Co.'s [11C]L-235 can be used to assess target engagement of cathepsin K inhibitors
Read More
AbbVie initiates first-in-human study of ABBV-623 and ABBV-992
Read More
Nanjing Ruijie Pharma divulges ACC inhibitors
Read More
Nerviano Medical Sciences patents IDH inhibitors
Read More
Bayer presents new alpha2C-adrenoceptor antagonists
Read More
Jiangsu Simcere Pharmaceutical identifies new PRMT5 inhibitors
Read More
Shanghai SIMR Biotech synthesizes new PLA2G7 inhibitors
Read More
Phase I data for anti-PCSK9 peptide vaccine candidates AT-04A and AT-06A
Read More
Second cohort data from phase I/II study of NOX-A12 in glioblastoma multiforme
Read More
GPR55 promotes NASH development through ACC activation
Read More
EC-11770 shows broad-spectrum activity in nontuberculous mycobacterial infection models
Read More
Inflammation, depression share "core biological process"
Read More
SPK-10000, a liver-targeted gene therapy for the treatment of hereditary angioedema
Read More
Preclinical data show antiviral and anti-inflammatory activity of balixafortide in COVID-19
Read More
AB Science suspends inclusion in masitinib trials
Read More
Phase IIb study of vamorolone in Duchenne muscular dystrophy meets primary endpoint
Read More
FDA clears IND for anti-CD73 antibody HLX-23 for advanced solid tumors
Read More
Pivotal study of venglustat in ADPKD stopped for futility
Read More
CARB-X supports BioVersys' development of pyrrolocytosines targeting antibiotic-resistant bacteria
Read More
Neuren holds pre-IND meetings for phase II trials of NNZ-2591 for neurological disorders
Read More